13 research outputs found
HIV-1 Vpr and p21 restrict LINE-1 mobility
Long interspersed element-1 (LINE-1, L1) composes ∼17% of the human genome. However, genetic interactions between L1 and human immunodeficiency virus type 1 (HIV-1) remain poorly understood. In this study, we found that HIV-1 suppresses L1 retrotransposition. Notably, HIV-1 Vpr strongly inhibited retrotransposition without inhibiting L1 promoter activity. Since Vpr is known to regulate host cell cycle, we examined the possibility whether Vpr suppresses L1 retrotransposition in a cell cycle dependent manner. We showed that the inhibitory effect of a mutant Vpr (H71R), which is unable to arrest the cell cycle, was significantly relieved compared with that of wild-type Vpr, suggesting that Vpr suppresses L1 mobility in a cell cycle dependent manner. Furthermore, a host cell cycle regulator p21Waf1 strongly suppressed L1 retrotransposition. The N-terminal kinase inhibitory domain (KID) of p21 was required for this inhibitory effect. Another KID-containing host cell cycle regulator p27Kip1 also strongly suppressed L1 retrotransposition. We showed that Vpr and p21 coimmunoprecipitated with L1 ORF2p and they suppressed the L1 reverse transcriptase activity in LEAP assay, suggesting that Vpr and p21 inhibit ORF2p-mediated reverse transcription. Altogether, our results suggest that viral and host cell cycle regulatory machinery limit L1 mobility in cultured cells
Characterization of LINE-1 Ribonucleoprotein Particles
The average human genome contains a small cohort of active L1 retrotransposons that encode two proteins (ORF1p and ORF2p) required for their mobility (i.e., retrotransposition). Prior studies demonstrated that human ORF1p, L1 RNA, and an ORF2p-encoded reverse transcriptase activity are present in ribonucleoprotein (RNP) complexes. However, the inability to physically detect ORF2p from engineered human L1 constructs has remained a technical challenge in the field. Here, we have employed an epitope/RNA tagging strategy with engineered human L1 retrotransposons to identify ORF1p, ORF2p, and L1 RNA in a RNP complex. We next used this system to assess how mutations in ORF1p and/or ORF2p impact RNP formation. Importantly, we demonstrate that mutations in the coiled-coil domain and RNA recognition motif of ORF1p, as well as the cysteine-rich domain of ORF2p, reduce the levels of ORF1p and/or ORF2p in L1 RNPs. Finally, we used this tagging strategy to localize the L1–encoded proteins and L1 RNA to cytoplasmic foci that often were associated with stress granules. Thus, we conclude that a precise interplay among ORF1p, ORF2p, and L1 RNA is critical for L1 RNP assembly, function, and L1 retrotransposition
Instabilité génomique associée à la rétrotransposition du LINE-1 humain
Le rétrotransposon LINE-1 (Ll) représente environ 17 % du génome humain. Du fait de son grand nombre de copies, il est impliqué dans des remaniements génomiques associés à des évènements de recombinaison homologue entre sites hétérologues. De plus, même si la vaste majorité des éléments Ll sont inactifs, certains sont encore capables de se mobiliser par rétrotransposition. Ll est donc un agent mutagène par insertion. De plus, des travaux ont aussi montré que les rétrotransposons actifs étaient impliqués dans la mobilisation d'autres séquences pour produire des rétro-pseudogènes ou amplifier d’autres séquences répétées. Finalement, des études récentes ont montré que l’élément Ll pourrait être associé à de nouveaux réarrangements génomiques produits lors de l'insertion, tels que des délétions génomiques de grande taille. En conclusion, Ll peut être considéré comme un facteur important qui a affecté et modelé le génome humain par l'intermédiaire de plusieurs mécanismes
Biochemical Approaches to Study LINE-1 Reverse Transcriptase Activity In Vitro
International audienc
Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase
Long Interspersed Element-1 (LINE-1 or L1) sequences comprise ∼17% of human DNA and ongoing L1 retrotransposition continues to impact genome evolution. The L1-encoded proteins also can mobilize other cellular RNAs (e.g., Alu retrotransposons, SVA retrotransposons, and U6 snRNAs), which comprise ∼13% of human DNA. Here, we demonstrate that the trans-mediated mobilization of non-L1 RNAs can occur by either template choice or template-switching mechanisms. Remarkably, these mechanisms are not mutually exclusive, as both processes can operate sequentially on the same RNA template. Finally, we provide evidence that efficient U6 snRNA retrotransposition requires both ORF1p and ORF2p, providing indirect evidence for the action of ORF1p in U6 snRNA retrotransposition. Thus, we propose that the LINE-1-encoded reverse transcriptase can mediate the retrotransposition of non-L1 RNAs by distinct mechanisms
Palladium-Catalyzed Direct Arylation of Luminescent Bis-Cyclometalated Iridium(III) Complexes Incorporating C^N- or O^O-Coordinating Thiophene-Based Ligands: an Efficient Method for Color Tuning.
International audienceWe report the palladium-catalyzed direct 5-arylation of both metalated and nonmetalated thiophene moieties of iridium complexes 2, 3, and 4 with aryl halides via C-H bond functionalization. This method opens new routes to varieties of Ir complexes in only one step, allowing easy modification of the nature of the ligand. The photophysical properties of the new functionalized complexes have been studied by means of absorption and emission spectroscopy. The extension of the π-conjugated system induces a bathochromic and hyperchromic shift of the absorption spectra, an effect reproduced by first principle calculations. Indeed, the bathochromic shifts are related to a more delocalized nature of the excited-states. All complexes are photoluminescent in the red region of the spectrum. This study establishes that arylation of the thienyl ring affects strongly the electronic properties of the resulting complexes, even when the thienyl ring is remote and not directly metalated to the iridium center, as in the thienyltrifluoroacetonate complex 4